MR imaging and MR-guided biopsy of the prostate at 3T

Katarzyna J. Macura; Jurgen J. Fütterer

doi:10.1017/CBO9780511978968.015

Chapter 13 - MR imaging and MR-guided biopsy of the prostate at 3T

Published online by Cambridge University Press: 05 August 2011

Katarzyna J. Macura and

Jurgen J. Fütterer

Edited by

Ihab R. Kamel and

Elmar M. Merkle

Show author details

Ihab R. Kamel: Affiliation:
The Johns Hopkins University School of Medicine
Elmar M. Merkle: Affiliation:
Duke University School of Medicine, North Carolina

Book contents

Get access

Summary

Introduction

Prostate cancer is a major public health and socioeconomic problem throughout the world. Prostate cancer is the most frequently diagnosed cancer in men. The 2009 report from the American Cancer Society projected 192 280 new cases of prostate cancer in the USA in 2009. With an estimated 27 360 deaths in the USA in 2009, prostate cancer is the second-leading cause of cancer death in men [1]. The high incidence of prostate cancer, combined with earlier detection and stage migration towards the smaller cancer volumes at the time of diagnosis, and the slow natural progression and heterogeneous biologic behavior of the disease make the management of prostate cancer a very complex and controversial issue. There is a wide discrepancy between the number of men diagnosed and those dying from prostate cancer. Incidence rates for prostate cancer have increased substantially over the past 20 years, in large part reflecting changes in prostate cancer screening with the prostate-specific antigen (PSA) blood test. In addition to PSA, screening for prostate cancer involves digital rectal examination (DRE) and transrectal ultrasonography (TRUS) with biopsy. Although elevated PSA levels can be suggestive of malignancy, benign conditions such as benign prostatic hyperplasia or prostatitis can also lead to PSA elevation [2]. It was demonstrated that only 25–40% of men with PSA above the 4 ng/ml threshold will be diagnosed with cancer, leading to about 60–75% of men in the PSA range 4–10 ng/ml undergoing an unnecessary biopsy [3]. In about 14% of men with prostate cancer, diagnosis can be established on the basis of DRE alone [4]. About 15% of men over the age of 60 have prostate cancer that is clinically silent, i.e., not detectable on DRE or with a PSA level of less than 4 ng/ml [5]. Thus, TRUS-guided core prostate biopsies are being used routinely to systematically sample the entire gland in patients with abnormal DRE and/or elevated PSA in the search for prostate cancer. Since prostate cancer is an age-related disease, the increasing life expectancy will result in further increase of both the incidence of and the deaths related to prostate cancer [6].

Type: Chapter
Information: Body MR Imaging at 3 Tesla , pp. 178 - 196

DOI: https://doi.org/10.1017/CBO9780511978968.015 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Cancer SocietyCancer Facts & Figures 2009AtlantaAmerican Cancer Society 2009Google Scholar

Bosch, JLBohnen, AMGroeneveld, FPValidity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: the Krimpen StudyEur Urol 2004 46 753CrossRef Google Scholar PubMed

Catalona, WJSmith, DSRatliff, TLMeasurement of prostate-specific antigen in serum as a screening test for prostate cancerN Engl J Med 1991 324 1156CrossRef Google Scholar PubMed

Okotie, OTRoehl, KAHan, MCharacteristics of prostate cancer detected by digital rectal examination onlyUrology 2007 70 1117CrossRef Google Scholar PubMed

Thompson, IMPauler, DKGoodman, PJPrevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliterN Engl J Med 2004 350 2239CrossRef Google Scholar PubMed

Jemal, ASiegel, RWard, ECancer statistics, 2009CA Cancer J Clin 2009 59 225CrossRef Google Scholar PubMed

Mettlin, C 1990

Levine, MAIttman, MMelamed, JTwo consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancerJ Urol 1998 159 471CrossRef Google Scholar PubMed

Steven, DMcCabe, KPeretsman, SProstate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancerJ Urol 1998 159 1606Google Scholar

Byar, DPMostofi, FKCarcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section techniqueCancer 1972 30 53.0.CO;2-S>CrossRef Google Scholar PubMed

Obek, CLouis, PCivantos, FComparison of digital rectal examination and biopsy results with the radical prostatectomy specimenJ Urol 1999 161 494CrossRef Google Scholar PubMed

Salomon, LColombel, MPatard, JJValue of ultrasound-guided systematic sextant biopsies in prostate tumor mappingEur Urol 1999 35 289CrossRef Google Scholar PubMed

Wang, LIncremental value of magnetic resonance imaging in the advanced management of prostate cancerWorld J Radiol 2009 1 3CrossRef Google Scholar PubMed

Beyersdorff, DWinkel, AHamm, BMR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial resultsRadiology 2005 234 576CrossRef Google Scholar

Anastasiadis, AGLichy, MPNagele, UMRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsiesEur Urol 2006 50 738CrossRef Google Scholar PubMed

Engelhard, KHollenbach, HPKiefer, BProstate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy deviceEur Radiol 2006 16 1237CrossRef Google Scholar

Hambrock, TSomford, DMHoeks, CMagnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigenJ Urol 2010 183 520CrossRef Google Scholar PubMed

Kim, HWBuckley, DLPeterson, DMIn vivo prostate magnetic resonance imaging and magnetic resonance spectroscopy at 3 Tesla using a transceive pelvic phased array coil: preliminary resultsInvest Radiol 2003 38 443CrossRef Google Scholar PubMed

Sosna, JPedrosa, IDewolf, WCMR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 TeslaAcad Radiol 2004 11 857CrossRef Google Scholar PubMed

Bloch, BNRofsky, NMBaroni, RH3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; initial experienceAcad Radiol 2004 11 863Google Scholar PubMed

Heijmink, SWFütterer, JJHambrock, TProstate cancer: body-array versus endorectal coil MR imaging at 3 T – comparison of image quality, localization, and staging performanceRadiology 2007 244 184CrossRef Google Scholar

Futterer, JJHeijmink, SWScheenen, TWProstate cancer: local staging at 3-T endorectal MRI – early experienceRadiology 2006 238 184CrossRef Google Scholar PubMed

Futterer, JJScheenen, TWHuisman, HJInitial experience of 3 Tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostateInvest Radiol 2004 39 671CrossRef Google Scholar PubMed

Hailton, GMiddelton, MChoi, SImproved MR spectral analysis for a PFC-filled endo-rectal prostate surface coil compared to an air-filled coilProceedings 15th Scientific Meeting, International Society for Magnetic Resonance in MedicineBerlin 2007 1400Google Scholar

Rosen, YBloch, BNLenkinski, RE3T MR of the prostate: reducing susceptibility gradients by inflating the endorectal coil with a barium sulfate suspensionMagn Reson Med 2007 57 898CrossRef Google Scholar PubMed

Noworolski, SMCrane, JCVigneron, DBKurhanewicz, JA clinical comparison of rigid and inflatable endorectal-coil probes for MRI and 3D MR spectroscopic imaging (MRSI) of the prostateJ Magn Reson Imaging 2008 27 1077CrossRef Google Scholar PubMed

Ikonen, SKivisaari, LVehmas, TOptimal timing of post-biopsy MRI of the prostateActa Radiol 2001 42 70CrossRef Google Scholar PubMed

Hennig, JScheffler, KHyperechoesMagn Reson Med 2001 46 6CrossRef Google Scholar PubMed

de Bazelaire, CMDuhamel, GDRofsky, NMAlsop, DCMRI relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary resultsRadiology 2004 230 652CrossRef Google Scholar

Hricak, HWilliams, RDSpring, DBAnatomy and pathology of the male pelvis by magnetic resonance imagingAJR Am J Roentgenol 1983 141 1101CrossRef Google Scholar PubMed

Bezzi, MKressel, HYAllen, KSProstatic carcinoma: staging with MRI at 1.5TRadiology 1988 168 339CrossRef Google Scholar

Hricak, HChoyke, PLEberhardt, SCImaging prostate cancer: a multidisciplinary perspectiveRadiology 2007 243 28CrossRef Google Scholar PubMed

Rifkin, MDZerhouni, EAGatsonis, CAComparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trialN Engl J Med 1990 323 621CrossRef Google Scholar PubMed

Schnall, MDPollack, HMMagnetic resonance imaging of the prostate glandUrol Radiol 1990 12 109CrossRef Google Scholar PubMed

Schiebler, MLYankaskas, BCTempany, CMR imaging in adenocarcinoma of the prostate: interobserver variation and efficacy for determining stage C diseaseAJR Am J Roentgenol 1992 158 559CrossRef Google Scholar PubMed

Turkbey, BPinto, PAMani, HProstate cancer: value of multiparametric MRI at 3 T for detection – histopathologic correlationRadiology 2010 255 89CrossRef Google Scholar

Yu, KKHricak, HAlagappan, RDetection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MRI: multivariate feature analysisRadiology 1997 202 697CrossRef Google Scholar PubMed

Outwater, EKPetersen, ROSiegelman, ESProstate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR imagesRadiology 1994 193 333CrossRef Google Scholar PubMed

Bernstein, MRCangiano, TD'Amico, AEndorectal coil magnetic resonance imaging and clinicopathologic findings in T1c adenocarcinoma of the prostateUrol Oncol 2000 5 104CrossRef Google Scholar PubMed

May, FTreumann, TDettmar, PLimited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancerBJU Int 2001 87 66CrossRef Google Scholar PubMed

Cornud, FFlam, TChauveinc, LExtraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MRI examination resultsRadiology 2002 224 203CrossRef Google Scholar PubMed

Sonnad, SSLanglotz, CPSchwartz, JSAccuracy of MR imaging for staging prostate cancer: a metaanalysis to examine the effect of technologic changeAcad Radiol 2001 8 149CrossRef Google Scholar

Engelbrecht, MRJager, GJLaheij, RJLocal staging of prostate cancer using magnetic resonance imaging: a meta-analysisEur Radiol 2002 12 2294CrossRef Google Scholar PubMed

Tien, RDFelsberg, GJFriedman, HMR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequencesAJR Am J Roentgenol 1994 162 671CrossRef Google Scholar PubMed

Sugahara, TKorogi, YKochi, MUsefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomasJ Magn Reson Imaging 1999 9 533.0.CO;2-2>CrossRef Google Scholar PubMed

Castillo, MSmith, JKKwock, LApparent diffusion coefficients in the evaluation of high-grade cerebral gliomasAJNR Am J Neuroradial 2001 22 60Google Scholar PubMed

Anderson, AWXie, JPizzonia, JEffects of cell volume fraction changes on apparent diffusion in human cellsMagn Reson Imaging 2000 18 689CrossRef Google Scholar PubMed

Desouza, NMReinsberg, SAScurr, EDMagnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodulesBr J Radiol 2007 80 90CrossRef Google Scholar PubMed

Ichikawa, THaradome, HHachiya, JDiffusion-weighted MRI with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesionsAJR Am J Roentgenol 1998 170 397CrossRef Google Scholar PubMed

Ichikawa, THaradome, HHachiya, JDiffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patientsAbdom Imaging 1999 24 456CrossRef Google Scholar PubMed

Gibbs, PTozer, DJLiney, GPComparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostateMagn Reson Med 2001 46 1054CrossRef Google Scholar PubMed

Bashar, IIn vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imagingJ Magn Reson Imaging 2002 16 196Google Scholar

Hosseinzadeh, KSchwarz, SDEndorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissueJ Magn Reson Imaging 2004 20 654CrossRef Google Scholar PubMed

Issa, BIn vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imagingJ Magn Reson Imaging 2002 16 196CrossRef Google Scholar PubMed

Sato, CNaganawa, SNakamura, TDifferentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostateJ Magn Reson Imaging 2005 21 258CrossRef Google Scholar PubMed

Kozlowski, PChang, SDGoldenberg, SLDiffusion-weighted MR imaging in prostate cancer – comparison between single-shot fast spin echo and echo planar imaging sequencesMagn Reson Imaging 2008 26 72CrossRef Google Scholar

Kim, CKPark, BKHan, JJDiffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary resultsJ Comput Assist Tomogr 2007 31 449CrossRef Google Scholar

Gibbs, PPickles, MDTurnbull, LWRepeatability of echo-planar-based diffusion measurements of the human prostate at 3TMagn Reson Imaging 2007 25 1423CrossRef Google Scholar

Miao, HFukatsu, HIshigaki, TProstate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imagingEur J Radiol 2007 61 297CrossRef Google Scholar PubMed

Gibbs, PPickles, MDTurnbull, LWDiffusion imaging of the prostate at 3.0 TeslaInvest Radiol 2006 41 185CrossRef Google Scholar PubMed

Pickles, MDGibbs, PSreenivas, MTurnbull, LWDiffusion-weighted imaging of normal and malignant prostate tissue at 3.0TJ Magn Reson Imaging 2006 23 130CrossRef Google Scholar PubMed

Manenti, GCarlani, MMancino, SDiffusion tensor magnetic resonance imaging of prostate cancerInvest Radiol 2007 42 412CrossRef Google Scholar PubMed

Desouza, NMRiches, SFVanas, NJDiffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancerClin Radiol 2008 63 774CrossRef Google Scholar PubMed

Scheidler, JHricak, HVigneron, DBProstate cancer: localization with three-dimensional proton MR spectroscopic imaging – clinicopathologic studyRadiology 1999 213 473CrossRef Google Scholar PubMed

Kurhanewicz, JVigneron, DBHricak, HThree-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24–0.7-cm3) spatial resolutionRadiology 1996 198 795CrossRef Google Scholar PubMed

Denis, LJMurphy, GPSchroeder, FHReport of the consensus workshop on screening and global strategy for prostate cancerCancer 1995 75 11873.0.CO;2-G>CrossRef Google Scholar PubMed

Coakley, FVQayyum, AKurhanewicz, JMagnetic resonance imaging and spectroscopic imaging of prostate cancerJ Urol 2003 170 S69CrossRef Google Scholar PubMed

Liney, GPTurnbull, LWKnowles, AJIn vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate glandNMR Biomed 1999 12 393.0.CO;2-1>CrossRef Google Scholar PubMed

Kurhanewicz, JSwanson, MGNelson, SJCombined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancerJ Magn Reson Imaging 2002 16 451CrossRef Google Scholar PubMed

Shukla-Dave, AHricak, HMoskowitz, CDetection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyaminesRadiology 2007 245 499CrossRef Google Scholar PubMed

Males, RGVigneron, DBStar-Lack, JClinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imagingMagn Reson Med 2000 43 173.0.CO;2-6>CrossRef Google Scholar PubMed

Zakian, KLEberhardt, SHricak, HTransition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging – initial resultsRadiology 2003 229 241CrossRef Google Scholar PubMed

Wefer, AEHricak, HVigneron, DBSextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histologyJ Urol 2000 164 400CrossRef Google Scholar PubMed

Hasumi, MSuzuki, KTaketomi, AThe combination of multivoxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancerAnticancer Res 2003 23 4223Google Scholar

Portalez, DMalavaud, BHerigault, GPredicting prostate cancer with dynamic endorectal coil MR and proton spectroscopic MRIJ Radiol 2004 85 1999CrossRef Google Scholar

Squillaci, EManenti, GMancino, SMR spectroscopy of prostate cancer. Initial clinical experienceJ Exp Clin Cancer Res 2005 24 523Google Scholar PubMed

Vilanova, JCBarcelo, JProstate cancer detection: MR spectroscopic imagingAbdom Imaging 2007 32 253CrossRef Google Scholar PubMed

Jung, JACoakley, FVVigneron, DVProstate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation systemRadiology 2004 233 701CrossRef Google Scholar PubMed

Futterer, JJHeijmink, SWScheenen, TWJProstate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imagingRadiology 2006 241 449CrossRef Google Scholar PubMed

Yu, KKScheidler, JHricak, HProstate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imagingRadiology 1999 213 481CrossRef Google Scholar PubMed

Wang, LHricak, HKattan, MWPrediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomogramsRadiology 2006 238 597CrossRef Google Scholar

Kurhanewicz, JVigneron, DBMales, RGThe prostate: MR imaging and spectroscopy. Present and futureRadiol Clin North Am 2000 38 115CrossRef Google Scholar PubMed

Zakian, KLSircar, KHricak, HCorrelation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomyRadiology 2005 234 804CrossRef Google Scholar PubMed

Lichy, MPPintaske, JKottke, R3D proton MR spectroscopic imaging of prostate cancer using a standard spine coil at 1.5 T in clinical routine: a feasibility studyEur Radiol 2005 15 653CrossRef Google Scholar

Chen, AXu, DSotto, C 2007

Scheenen, TWHeijmink, SWRoell, SAThree-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibilityRadiology 2007 245 507CrossRef Google Scholar

Scheenen, TWGambarota, GWeiland, EOptimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3.0TMagn Reson Med 2005 53 1268CrossRef Google Scholar

Rouviere, OHartman, RPLyonnet, D.Prostate, MRimaging at high-field strength: evolution or revolution?Eur Radiol 2006 16 276CrossRef Google Scholar PubMed

Prando, ABillis, AFocal prostatic atrophy: mimicry of prostatic cancer on TRUS and 3D-MRSI studiesAbdom Imaging 2009 34 271CrossRef Google Scholar PubMed

Qayyum, ACoakley, FVLu, YOrgan-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imagingAJR Am J Roentgenol 2004 183 1079CrossRef Google Scholar PubMed

Kaji, YKurhanewicz, JHricak, HLocalizing prostate cancer in the presence of post-biopsy change on MR images: role of proton MR spectroscopic imagingRadiology 1998 206 785CrossRef Google Scholar

Liney, GPTurnbull, LWKnowles, AJIn vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate glandNMR Biomed 1999 12 393.0.CO;2-1>CrossRef Google Scholar PubMed

Jager, GJRuijter, ETvan de Kaa, CADynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic resultsRadiology 1997 203 645CrossRef Google Scholar PubMed

Jager, GJRuijter, ETvan de Kaa, CALocal staging of prostate cancer with endorectal MRI: correlation with histopathologyAJR Am J Roentgenol 1996 166 845CrossRef Google Scholar PubMed

Barentsz, JOEngelbrecht, MJager, GJFast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancerJ Magn Reson Imaging 1999 10 2953.0.CO;2-Z>CrossRef Google Scholar PubMed

Namimoto, TMorishita, SSaitoh, RThe value of dynamic MR imaging for hypointensity lesions of the peripheral zone of the prostateComput Med Imaging Graph 1998 22 239CrossRef Google Scholar PubMed

Padhani, ARGapinski, CJMacvicar, DADynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSAClin Radiol 2000 55 99CrossRef Google Scholar

Padhani, ARHayes, CLandau, SReproducibility of quantitative dynamic MRI of normal human tissuesNMR Biomed 2002 15 143CrossRef Google Scholar PubMed

Engelbrecht, MRHuisman, HJLaheij, RJDiscrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MRIRadiology 2003 229 248CrossRef Google Scholar

Buckley, DLRoberts, CParker, GJProstate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging – initial experienceRadiology 2004 233 709CrossRef Google Scholar PubMed

Alonzi, RPadhani, ARAllen, CDynamic contrast enhanced MRI in prostate cancerEur J Radiol 2007 63 335CrossRef Google Scholar PubMed

d'Arcy, JACollins, DJPadhani, ARInformatics in Radiology (infoRAD): Magnetic Resonance Imaging Workbench: analysis and visualization of dynamic contrast-enhanced MR imaging dataRadiographics 2006 26 621CrossRef Google Scholar PubMed

Tofts, PSBrix, GBuckley, DLEstimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbolsJ Magn Reson Imaging 1999 10 2233.0.CO;2-S>CrossRef Google Scholar

Tofts, PSModeling tracer kinetics in dynamic Gd-DTPA MRIJ Magn Reson Imaging 1997 7 91CrossRef Google Scholar

Hara, NOkuizumi, MKoike, HDynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancerProstate 2005 62 140CrossRef Google Scholar PubMed

Fütterer, JJEngelbrecht, MRHuisman, HJStaging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readersRadiology 2005 237 541CrossRef Google Scholar PubMed

Nobauer-Huhmann, IMBa-Ssalamah, AMlynarik, VMagnetic resonance imaging contrast enhancement of brain tumors at 3 tesla versus 1.5 teslaInvest Radiol 2002 37 114CrossRef Google Scholar PubMed

Kim, CKPark, BKKim, BLocalization of prostate cancer using 3T MRI: comparison of T2-weighted and dynamic contrast-enhanced imagingJ Comput Assist Tomogr 2006 30 7CrossRef Google Scholar PubMed

Ocak, IBernardo, MMetzger, GDynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parametersAJR Am J Roentgenol 2007 189 849CrossRef Google Scholar

Kozlowski, PChang, SDJones, ECCombined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis – correlation with biopsy and histopathologyJ Magn Reson Imaging 2006 24 10813CrossRef Google Scholar PubMed

Reinsberg, SAPayne, GSRiches, SFCombined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detectionAJR Am J Roentgenol 2007 188 91CrossRef Google Scholar PubMed

Van Dorsten, FAVan der Graaf, MEngelbrecht, MRCombined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancerJ Magn Reson Imaging 2004 20 279CrossRef Google Scholar PubMed

Noworolski, SMHenry, RGVigneron, DBDynamic contrast-enhanced MRI in normal and abnormal prostate tissue as defined by biopsy, MRI, and MRSIMagn Reson Med 2005 53 249CrossRef Google Scholar PubMed

Kumar, VJagannathan, NRKumar, RTransrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4–10 ng/mlNMR Biomed 2007 20 11CrossRef Google Scholar PubMed

Singh, AKKruecker, JXu, SInitial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsyBJU Int 2008 101 841CrossRef Google Scholar PubMed

Kaplan, IOldenburg, NEMeskell, PReal time MRI-ultrasound image guided stereotactic prostate biopsyMagn Reson Imaging 2002 20 295CrossRef Google Scholar PubMed

Stoianovici, DSong, DPetrisor, D“MRI Stealth” robot for prostate interventionsMinim Invasive Ther Allied Technol 2007 16 241CrossRef Google Scholar PubMed

Yakar, DHambrock, THoeks, CBarentsz, JOFütterer, JJMagnetic resonance-guided biopsy of the prostate: feasibility, technique, and clinical applicationsTop Magn Reson Imaging 2008 19 291CrossRef Google Scholar PubMed

Book contents

Chapter 13 - MR imaging and MR-guided biopsy of the prostate at 3T

Summary

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive